ImmunityBio (FRA:26CA) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ImmunityBio's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 0.00%.

ImmunityBio's Revenue per Share for the three months ended in Sep. 2024 was €0.01.

ImmunityBio YoY Rev. per Sh. Growth Historical Data

The historical data trend for ImmunityBio's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio YoY Rev. per Sh. Growth Chart

ImmunityBio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

-80.00

100.00

-50.00

ImmunityBio Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-	-	-100.00	-	-

ImmunityBio YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ImmunityBio's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.001	-	0.001)	/	\| 0.001 \|
=	0.00 %

ImmunityBio's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(0.008	-	0)	/	\| 0 \|
=	N/A %

ImmunityBio YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ImmunityBio's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunityBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (FRA:26CA) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

IBRX:USA 26CA:Germany

Address

3530 John Hopkins Court, San Diego, CA, USA, 92121

Website

https://www.immunitybio.com

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

ImmunityBio Headlines

No Headlines